Clinical Trial Update: A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures [Phase 3]

View source ↗

Summary

Phase 3 long-term follow-up study of levetiracetam (L059) in epilepsy with partial-onset seizures completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizure

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Japan Co. Ltd. | Conditions: Epilepsies, Partial | Phase 3 | Status: COMPLETED | Results posted: 2012-01-16